Free Webex Call
The Global Eye Drop Market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027. The market is anticipated to grow on account of increasing instances of eye infection in the population. Higher prevalence of eye diseases like eye dryness, redness, itching in the eyes, conjunctivitis, soreness, glaucoma, etc. further drive the growth of the Global Eye Drop Market in the upcoming five years. Excessive screen time and penetration of smart phones, laptops, television, and electronics further supports the growth of the Global Eye Drop Market in the next five years. The governments around the world are actively investing in the healthcare industry and increasing the production of the pharmaceuticals and therapeutics products in the recent years. Growing imports & exports of the pharmaceutical & therapeutics products like eye drops further aid the growth of the Global Eye Drop Market in the future five years. Also, the consumers in the country have been spending over healthcare services to attain excellent patient care. Rising disposable income of the population also sustains the market growth. Technological advancement in product manufacturing, expanding logistics sector with easy distribution of the products further aids the growth of the Global Eye Drop Market in the forecast period. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Eye Drop Market is segmented by type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution. Based on type, the market is further differentiated into prescription and over the counter. Prescription type eye drops are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on account of increasing instances of eye diseases. Increasing instances of diabetes and thus higher risks of catching eye diseases, vision impairment, also aids to the growth of the segment. Over the counter eye drops are expected to achieve the fastest growth owing to increasing tendency of the consumers to self-medicate their conditions of eye burning sensations and redness, etc. Increasing common eye itchiness and dryness due to prolonged screen times also aid to the growth of the sub-segment along with the growth of the Global Eye Drop Market in the future five years.
Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc. are among the major market players in the Global Eye Drop Market.
Years considered for this report:
- Historical Years: 2017- 2020
- Base Year: 2021
- Estimated Year: 2022E
- Forecast Period: 2023F - 2027F
Objective of the Study:
- To analyze the historical growth in the market size of the Global Eye Drop Market from 2017 to 2021.
- To estimate and forecast the market size of the Global Eye Drop Market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast the Global Eye Drop Market based on type, drug class, disease indication, distribution channel, competitional landscape, and regional distribution.
- To identify dominant region or segment in the Global Eye Drop Market.
- To identify drivers and challenges for the Global Eye Drop Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Eye Drop Market.
- To identify and analyze the profile of leading players operating in the Global Eye Drop Market.
- To identify key sustainable strategies adopted by the market players in the Global Eye Drop Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the globe.
The publisher calculated the market size of the Global Eye Drop Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Eye drops manufacturers and suppliers
- Distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to eye drops
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.
Report Scope:
In this report, the Global Eye Drop Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Eye Drop Market, By Type:
- Prescription
- Over-The-Counter
Eye Drop Market, By Drug Class:
- Anti-allergy
- Anti-glaucoma
- Anti-inflammatory
- Anti-VEGF
- Others
Eye Drop Market, By Disease Indication:
- Eye Allergy
- Glaucoma
- Eye Infections
- Dry Eye Diseases
- Retinal Disorders
Eye Drop Market, By Distribution Channel:
- Hospitals Pharmacy
- Retail Pharmacy
- Online Pharmacy
Eye Drop Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Russia Federation
- United Kingdom
- Germany
- France
- Spain
- Italy
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Indonesia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Eye Drop Market.
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.
Table of Contents
1. Product Overview2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Eye Drop Market
5. Voice of Customer
5.1. Brand Awareness
5.2. Factors Contributing to demand for Eye Drops
5.3. Demand, By Drug Class
5.4. Demand, By Disease Indication
5.5. Preference, By Distribution Channel
6. Global Eye Drop Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Prescription v/s Over-The-Counter)
6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)
6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. North America Eye Drop Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Drug Class
7.2.3. By Disease Indication
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Eye Drop Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Drug Class
7.3.1.2.3. By Disease Indication
7.3.1.2.4. By Distribution Channel
7.3.2. Canada Eye Drop Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Drug Class
7.3.2.2.3. By Disease Indication
7.3.2.2.4. By Distribution Channel
7.3.3. Mexico Eye Drop Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Drug Class
7.3.3.2.3. By Disease Indication
7.3.3.2.4. By Distribution Channel
8. Europe Eye Drop Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Drug Class
8.2.3. By Disease Indication
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Russia Federation Eye Drop Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Drug Class
8.3.1.2.3. By Disease Indication
8.3.1.2.4. By Distribution Channel
8.3.2. United Kingdom Eye Drop Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Drug Class
8.3.2.2.3. By Disease Indication
8.3.2.2.4. By Distribution Channel
8.3.3. Germany Eye Drop Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Drug Class
8.3.3.2.3. By Disease Indication
8.3.3.2.4. By Distribution Channel
8.3.4. France Eye Drop Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Drug Class
8.3.4.2.3. By Disease Indication
8.3.4.2.4. By Distribution Channel
8.3.5. Spain Eye Drop Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Drug Class
8.3.5.2.3. By Disease Indication
8.3.5.2.4. By Distribution Channel
8.3.6. Italy Eye Drop Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Type
8.3.6.2.2. By Drug Class
8.3.6.2.3. By Disease Indication
8.3.6.2.4. By Distribution Channel
9. Asia-Pacific Eye Drop Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Drug Class
9.2.3. By Disease Indication
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Eye Drop Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Drug Class
9.3.1.2.3. By Disease Indication
9.3.1.2.4. By Distribution Channel
9.3.2. India Eye Drop Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Drug Class
9.3.2.2.3. By Disease Indication
9.3.2.2.4. By Distribution Channel
9.3.3. Japan Eye Drop Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Drug Class
9.3.3.2.3. By Disease Indication
9.3.3.2.4. By Distribution Channel
9.3.4. Australia Eye Drop Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Drug Class
9.3.4.2.3. By Disease Indication
9.3.4.2.4. By Distribution Channel
9.3.5. South Korea Eye Drop Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Drug Class
9.3.5.2.3. By Disease Indication
9.3.5.2.4. By Distribution Channel
9.3.6. Indonesia Eye Drop Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Type
9.3.6.2.2. By Drug Class
9.3.6.2.3. By Disease Indication
9.3.6.2.4. By Distribution Channel
10. South America Eye Drop Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Drug Class
10.2.3. By Disease Indication
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Eye Drop Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Drug Class
10.3.1.2.3. By Disease Indication
10.3.1.2.4. By Distribution Channel
10.3.2. Argentina Eye Drop Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Drug Class
10.3.2.2.3. By Disease Indication
10.3.2.2.4. By Distribution Channel
10.3.3. Colombia Eye Drop Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Drug Class
10.3.3.2.3. By Disease Indication
10.3.3.2.4. By Distribution Channel
11. Middle East and Africa Eye Drop Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Drug Class
11.2.3. By Disease Indication
11.2.4. By Distribution Channel
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. Turkey Eye Drop Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Drug Class
11.3.1.2.3. By Disease Indication
11.3.1.2.4. By Distribution Channel
11.3.2. South Africa Eye Drop Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Drug Class
11.3.2.2.3. By Disease Indication
11.3.2.2.4. By Distribution Channel
11.3.3. Saudi Arabia Eye Drop Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Drug Class
11.3.3.2.3. By Disease Indication
11.3.3.2.4. By Distribution Channel
11.3.4. UAE Eye Drop Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Type
11.3.4.2.2. By Drug Class
11.3.4.2.3. By Disease Indication
11.3.4.2.4. By Distribution Channel
11.3.5. Kuwait Eye Drop Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Type
11.3.5.2.2. By Drug Class
11.3.5.2.3. By Disease Indication
11.3.5.2.4. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Johnson & Johnson Inc.
14.2. Genentech, Inc. (Roche)
14.3. Alcon Inc.
14.4. Pfizer, Inc.
14.5. Bausch Health Companies, Inc.
14.6. Bayer Corporation
14.7. Allergan, Inc. (AbbVie)
14.8. Abbott Laboratories Inc.
14.9. KC Pharmaceuticals, Inc.
14.10. Akorn, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
List of FiguresFigure 1: Global Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 3: Global Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 4: Global Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 5: Global Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 6: Global Eye Drop Market Share, By Region, By Value, 2017-2027F
Figure 7: Global Eye Drop Market Share, By Company, By Value, 2021
Figure 8: Global Eye Drop Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Eye Drop Market Map, By Drug Class, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Eye Drop Market Map, By Disease Indication, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: Global Eye Drop Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Eye Drop Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: North America Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 14: North America Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 15: North America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 16: North America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 17: North America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 18: North America Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 19: United States Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 20: United States Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 21: United States Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 22: United States Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 23: United States Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 24: Canada Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 25: Canada Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 26: Canada Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 27: Canada Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 28: Canada Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: Mexico Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 30: Mexico Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 31: Mexico Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 32: Mexico Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 33: Mexico Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 34: Europe Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 35: Europe Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 36: Europe Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 37: Europe Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 38: Europe Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 39: Europe Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 40: Russia Federation Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 41: Russia Federation Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 42: Russia Federation Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 43: Russia Federation Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 44: Russia Federation Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 45: United Kingdom Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 46: United Kingdom Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 47: United Kingdom Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 48: United Kingdom Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 49: United Kingdom Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 50: Germany Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 51: Germany Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 52: Germany Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 53: Germany Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 54: Germany Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 55: France Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 56: France Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 57: France Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 58: France Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 59: France Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 60: Spain Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 61: Spain Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 62: Spain Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 63: Spain Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 64: Spain Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 65: Italy Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 66: Italy Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 67: Italy Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 68: Italy Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 69: Italy Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 70: Asia-Pacific Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 71: Asia-Pacific Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 72: Asia-Pacific Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 73: Asia-Pacific Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 74: Asia-Pacific Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 75: Asia-Pacific Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 76: China Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 77: China Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 78: China Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 79: China Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 80: China Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 81: India Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 82: India Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 83: India Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 84: India Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 85: India Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 86: Japan Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 87: Japan Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 88: Japan Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 89: Japan Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 90: Japan Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 91: Australia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 92: Australia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 93: Australia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 94: Australia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 95: Australia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 96: South Korea Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 97: South Korea Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 98: South Korea Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 99: South Korea Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 100: South Korea Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 101: Indonesia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 102: Indonesia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 103: Indonesia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 104: Indonesia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 105: Indonesia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 106: South America Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 107: South America Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 108: South America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 109: South America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 110: South America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 111: South America Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 112: Brazil Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 113: Brazil Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 114: Brazil Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 115: Brazil Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 116: Brazil Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 117: Argentina Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 118: Argentina Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 119: Argentina Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 120: Argentina Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 121: Argentina Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 122: Colombia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 123: Colombia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 124: Colombia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 125: Colombia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 126: Colombia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 127: Middle East & Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 128: Middle East & Africa Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 129: Middle East & Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 130: Middle East & Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 131: Middle East & Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 132: Middle East & Africa Eye Drop Market Share, By Country, By Value, 2017-2027F
Figure 133: Turkey Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 134: Turkey Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 135: Turkey Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 136: Turkey Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 137: Turkey Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 138: South Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 139: South Africa Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 140: South Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 141: South Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 142: South Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 143: Saudi Arabia Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 144: Saudi Arabia Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 145: Saudi Arabia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 146: Saudi Arabia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 147: Saudi Arabia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 148: UAE Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 149: UAE Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 150: UAE Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 151: UAE Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 152: UAE Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 153: Kuwait Eye Drop Market Size, By Value (USD Million), 2017-2027F
Figure 154: Kuwait Eye Drop Market Share, By Type, By Value, 2017-2027F
Figure 155: Kuwait Eye Drop Market Share, By Drug Class, By Value, 2017-2027F
Figure 156: Kuwait Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F
Figure 157: Kuwait Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F
Companies Mentioned
- Johnson & Johnson Inc.
- Genentech, Inc. (Roche)
- Alcon Inc.
- Pfizer, Inc.
- Bausch Health Companies, Inc.
- Bayer Corporation
- Allergan, Inc. (AbbVie)
- Abbott Laboratories Inc.
- KC Pharmaceuticals, Inc.
- Akorn, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | May 2022 |
| Forecast Period | 2017 - 2027 |
| Estimated Market Value ( USD | $ 12549 Million |
| Forecasted Market Value ( USD | $ 19758 Million |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
